Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The US Food and Drug Administration (FDA) has completed inspecting Lannett's manufacturing facility in Philadelphia, Pennsylvania and Cody, Wyoming.
Subscribe to our email newsletter
The FDA has pointed minor observations in the company’s seven facilities in Philadelphia and five at Lannett‘s wholly owned subsidiary, Cody Laboratories, a manufacturer/supplier of pain management pharmaceutical products.
Lannett president and CEO Arthur Bedrosian said all of the observations have been corrected or will be shortly.
"We believe the positive inspection clears the way for a number of our product applications currently pending at the FDA, including a New Drug Application for Morphine Sulfate Oral Solution, to be approved for marketing," Bedrosian said.